Long-term outcome of chronic hepatitis C virus infection in a real-world setting: The German LOTOS study-Reference-Cited by-同舟云学术

Long-term outcome of chronic hepatitis C virus infection in a real-world setting: The German LOTOS study

Published:2017-07-18 Issue:10 Volume:37 Page:1468-1475
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Wedemeyer Heiner¹^ORCID,Reimer Jens²,Sandow Petra³,Hueppe Dietrich⁴,Lutz Thomas⁵,Gruengreiff Kurt⁶,Goelz Joerg⁷,Christensen Stefan⁸,Pfeiffer-Vornkahl Heike⁹,Alshuth Ulrich¹⁰,Manns Michael P.¹

Affiliation:

1. Department of Gastroenterology, Hepatology and Endocrinology; Hannover Medical School; Hannover Germany

2. Centre for Interdisciplinary Addiction Research; University of Hamburg; Hamburg Germany

3. Private Practice; Berlin Germany

4. Center of Gastroenterology; Herne Germany

5. Infektiologikum; Frankfurt Germany

6. Practice of Hepatology; Magdeburg Germany

7. Practice Center Kaiserdamm; Berlin Germany

8. Center for Interdisciplinary Medicine (CIM); Muenster Germany

9. e.factum-GmbH; Butzbach Germany

10. Roche Pharma AG; Grenzach-Wyhlen Germany

Funder

Abbott

Bristol-Myers Squibb

Gilead Sciences

Merck

Novartis

Roche

Roche Diagnostics

Siemens

AbbVie

Janssen-Cilag

Mundipharma

Roche and Sanofi-Aventis

Boehringer Ingelheim

Roche Pharma AG

Grenzach-Wyhlen

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13399/fullpdf

Reference21 articles.

1. Global epidemiology and genotype distribution of the hepatitis C virus infection;Gower;J Hepatol,2014

2. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013;GBD 2013 Mortality and Causes of Death Collaborators;Lancet,2015

3. A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin;Swain;Gastroenterology,2010

4. Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin;Manns;J Viral Hepat,2013

5. Is there sufficient evidence to recommend antiviral therapy in hepatitis C?;Meer;J Hepatol,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum MicroRNA Signatures in Recovery From Acute and Chronic Liver Injury and Selection for Liver Transplantation;Liver Transplantation;2020-05-29

2. Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals;Liver International;2020-04

3. The epidemiology of Hepatitis B, C and D in Germany: A scoping review;PLOS ONE;2020-03-09

4. Antiviral Therapies: A Critical Reappraisal;Myocarditis;2020

5. Fibrosis reversal after hepatitis C virus elimination;Current Opinion in Gastroenterology;2019-05